Status:
COMPLETED
Premixed vs Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation
Lead Sponsor:
Tanta University
Conditions:
Premixed
Sequential
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to compare premixed and sequential injections of lidocaine and bupivacaine for supraclavicular brachial plexus block in patients undergoing arteriovenous fistula creation.
Detailed Description
Hemodialysis is the common treatment for end-stage renal disease (ESRD) condition which improves quality of life and survival rate for this group of patients. Arteriovenous fistula (AVF) creation is t...
Eligibility Criteria
Inclusion
- Age from 18 to 65 years.
- Both sexes.
- American Society of Anesthesiology (ASA) physical status III.
- Undergoing arteriovenous Fistula creation.
Exclusion
- Allergy to local anesthetics.
- Body mass index (BMI) ≥ 35 kg/m2.
- Preoperative neurological deficit.
- Neuromuscular disorder.
- Psychiatric disorder.
- Coagulation disorder.
- Congestive heart failure.
- Pregnancy.
- Infection at the site of block.
Key Trial Info
Start Date :
August 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06570096
Start Date
August 24 2024
End Date
March 16 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527